Introduction
Rotarix contains the G1P(8) serotype, and is a human live attenuated vaccine. Both vaccines have similar efficacy and very safe side effect profiles. Rotarix can prevent severe infection requiring hospitalization in 85 to 96 % of cases. They have been included in the immunisation programmes of many countries worldwide and were found to be very effective and safe. We would recommend that all babies falling within the age group to take the vaccine.
Manufacturer
GSK
Prevention
Rotavirus